International Vaccine Institute

This early-stage study tests a new oral cholera vaccine called DuoChol in 60 healthy adults aged 18 to 45 in Sweden. Participants will receive either DuoChol or an existing cholera vaccine to compare safety and immune response. The goal is to gather initial data for future studie…

This study tests a bivalent HPV vaccine in healthy infants (9 months), toddlers (15 months), children (2-5 years), and unmarried young women (15-20 years) in Ghana. The goal is to see if the vaccine is safe and triggers a strong immune response. Participants receive one or two do…

This study will test the LC16m8 mpox vaccine in nearly 12,000 people aged 1 year and older in the Democratic Republic of Congo. The goal is to see if the vaccine is safe and provides strong protection against mpox. Participants will receive the vaccine and be monitored for side e…